Endometriosis Global Market Report 2024

Description

“Endometriosis Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endometriosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endometriosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The endometriosis market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Superficial Peritoneal Lesion; Endometrioma; Deeply Infiltrating Endometriosis; Other Types
2) By Treatment Type: Hormonal Therapy; Pain Management
3) By Drug: Oral Contraceptives; Progestins; Nonsteroidal Anti-Inflammatory Drugs (NSAIDs); Gonadotropin Releasing Hormone (GnRH) Analogues; Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs); Other Drugs
4) By End-User: Hospitals; Homecare; Specialty Centers; Other End-Users
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche AG; Merck And Co. Inc.; Abbvie Inc.; Bayer AG
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Endometriosis is a chronic medical condition characterized by the growth of tissue similar to the uterine lining (endometrium) outside the uterus. This condition often results in severe pelvic pain and can complicate fertility, significantly impacting an individual's overall well-being and ability to conceive.

Endometriosis presents in various forms, including superficial peritoneal lesions, endometrioma, deeply infiltrating endometriosis, and other less common manifestations. Superficial peritoneal lesions denote a specific type of abnormal tissue growth associated with endometriosis and typically necessitate treatments like hormonal therapy and pain management. Several drugs and therapies are available for managing this condition, including oral contraceptives, progestins, nonsteroidal anti-inflammatory drugs (NSAIDs), GnRH analogs, levonorgestrel-releasing intrauterine devices (LNR-IUDs), among others. These treatments are administered by different healthcare end-users, such as hospitals, homecare services, specialty centers, and others.

The endometriosis market research report is one of a series of new reports from The Business Research Company that provides endometriosis market statistics, including endometriosis industry global market size, regional shares, competitors with an endometriosis market share, detailed endometriosis market segments, market trends and opportunities and any further data you may need to thrive in the endometriosis industry. This endometriosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endometriosis market size has grown rapidly in recent years. It will grow from $1.27 billion in 2023 to $1.4 billion in 2024 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to delayed diagnosis and increased awareness, advances in laparoscopic surgery, hormonal therapies, patient advocacy and support groups.

The endometriosis market size is expected to see strong growth in the next few years. It will grow to $2.01 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to minimally invasive procedures, pharmaceutical innovations, genetic and epigenetic research, global expansion of women's healthcare. Major trends in the forecast period include patient-centered care, precision medicine, virtual care and telemedicine, fertility preservation.

The escalating prevalence of ovarian cancer is poised to be a driving force behind the anticipated growth of the endometriosis market. Ovarian cancer, a malignancy originating in the ovaries - vital female reproductive organs responsible for egg production and hormone secretion - is intrinsically linked to endometriosis. This condition heightens the risk of developing certain ovarian cancer subtypes, notably the endometrioid and precise cell cancer subtypes characterized by elevated estrogen concentrations, which can elevate ovarian cancer risk. As an illustration, data from the American Cancer Society in January 2023 projects around 19,710 new cases of ovarian cancer among women in the United States for 2023. Additionally, the Ovarian Cancer Research Alliance, a U.S.-based not-for-profit organization, reported 12,810 ovarian cancer-related fatalities in 2022, with a rise to 13,270 expected in 2023. Consequently, the surge in ovarian cancer incidence is a driving factor behind the expansion of the endometriosis market.

The upswing in government funding is anticipated to propel the growth of the endometriosis market. Government funding encompasses financial support provided to non-government entities, wherein all or a portion of the financial backing is supplied by government entities. Typically channeled through grants and contracts, government funding is instrumental in advancing endometriosis research, benefitting individual researchers and research institutions conducting clinical studies. As an example, in March 2022, the U.S. federal government unveiled a commitment of $92 million in funding for the National Institute of Child Health and Human Development (NICHD). The Department of Defense's Peer-Reviewed Medical Research Programme (PRMRP) continues to receive substantial support with $370 million in funding for endometriosis research. Consequently, the upsurge in government funding plays a pivotal role in propelling the growth of the endometriosis market.

The significant barrier to endometriosis treatment arises from the elevated costs associated with it, potentially impacting the overall growth of the endometriosis market. The substantial expenses tied to endometriosis treatment pose a formidable obstacle for many patients seeking care. This can exert an influence on the endometriosis treatment market by affecting the accessibility and affordability of treatments, consequently influencing market growth. As an example, in March 2023, the World Health Organization (WHO), a Switzerland-based intergovernmental organization, highlighted that certain endometriosis treatments can result in side effects, and endometriosis-related symptoms may sometimes reoccur after the conclusion of therapy. The choice of treatment is influenced by considerations such as individual effectiveness, potential adverse side effects, long-term safety, costs, and availability. Thus, the high cost of both diagnosis and treatment stands as a significant impediment to treatment for numerous patients, hindering the growth of the endometriosis market.

Prominent companies engaged in the endometriosis market are placing their focus on the development of innovative medications, including Myfembree, and securing approvals to introduce fresh treatment options for patients. The advent of novel medications for endometriosis addresses a previously unmet need for effective treatments. For instance, in August 2022, Myovant Sciences GmbH, a Switzerland-based biopharmaceutical company, in collaboration with Pfizer Inc., a U.S.-based pharmaceutical industry company, secured approval from the U.S. Food and Drug Administration (FDA) for Myfembree. This medication is designed for the management of moderate to severe pain associated with endometriosis in premenopausal women. Myfembree is a once-daily pill that combines three vital components such as relugolix, estradiol, and norethindrone acetate, offering proven relief to premenopausal women with two indications in a single pill. This presents an alternative treatment choice for women who cannot or prefer not to use hormone therapy.

In December 2021, Organon Group, a U.S.-based healthcare company, completed its acquisition of Forendo Pharma Ltd. for $954 million. This strategic acquisition is poised to bolster Organon's women's health pipeline by introducing new candidates specifically targeting endometriosis and polycystic ovarian syndrome (PCOS). Furthermore, it equips Forendo Pharma with the necessary resources and expertise to advance its endometriosis program into Phase II clinical studies. Forendo Pharma Ltd., a pharmaceutical company based in Finland, is dedicated to the development of oral endometriosis treatments.

Major players in the endometriosis market are Pfizer Inc., F. Hoffmann-La Roche AG, Merck And Co. Inc., Abbvie Inc., Bayer AG, Bristol-Myers Squibb Company, GlaxoSmithKline PLC, AstraZeneca PLC, Abbott Laboratories, Eli Lilly and Company, Mylan N.V., Astellas Pharma Inc., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Limited, Ipsen Pharma Biotech S.A.S., Cadila Pharmaceuticals Ltd., Gedeon Richter PLC, Torrent Pharmaceuticals Ltd., Neurocrine Biosciences Inc., Ferring Pharmaceuticals, Prestige Consumer Healthcare Inc., Almirall S.A, Evotec BioSystems GmbH, Serum Institute of India Pvt. Ltd., Kissei Pharmaceutical Co. Ltd., Sanofi India Ltd., DebioPharm Group, Repros Therapeutics Inc., Meditrina Pharmaceuticals Private Limited, Zenomed Healthcare Private Limited .

North America was the largest region in the endometriosis market in 2023. The regions covered in endometriosis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endometriosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endometriosis market consists of revenues earned by entities by providing services such as laparoscopy, nutritional counseling, physical therapy, diagnostic laparoscopy, fertility treatment, surgical interventions and complementary therapies. The market value includes the value of related goods sold by the service provider or included within the service offering. The endometriosis market also includes sales of birth control pills, patches and vaginal rings. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12381

1. Executive Summary

2. Endometriosis Market Characteristics

3. Endometriosis Market Trends And Strategies

4. Endometriosis Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Endometriosis Market Size and Growth

5.1. Global Endometriosis Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Endometriosis Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Endometriosis Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Endometriosis Market Segmentation

6.1. Global Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Superficial Peritoneal Lesion
Endometrioma
Deeply Infiltrating Endometriosis
Other Types
6.2. Global Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hormonal Therapy
Pain Management
6.3. Global Endometriosis Market, Segmentation By Drug, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral Contraceptives
Progestins
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs)
Gonadotropin Releasing Hormone (GnRH) Analogues
Levonorgestrel-Releasing Intrauterine Devices (LNR-IUDs)
Other Drugs
6.4. Global Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Homecare
Speciality Centers
Other End-Users

7. Endometriosis Market Regional And Country Analysis

7.1. Global Endometriosis Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Endometriosis Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Endometriosis Market

8.1. Asia-Pacific Endometriosis Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Endometriosis Market

9.1. China Endometriosis Market Overview
9.2. China Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Endometriosis Market

10.1. India Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Endometriosis Market

11.1. Japan Endometriosis Market Overview
11.2. Japan Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Endometriosis Market

12.1. Australia Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Endometriosis Market

13.1. Indonesia Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Endometriosis Market

14.1. South Korea Endometriosis Market Overview
14.2. South Korea Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Endometriosis Market

15.1. Western Europe Endometriosis Market Overview
15.2. Western Europe Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Endometriosis Market

16.1. UK Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Endometriosis Market

17.1. Germany Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Endometriosis Market

18.1. France Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Endometriosis Market

19.1. Italy Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Endometriosis Market

20.1. Spain Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Endometriosis Market

21.1. Eastern Europe Endometriosis Market Overview
21.2. Eastern Europe Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Endometriosis Market

22.1. Russia Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Endometriosis Market

23.1. North America Endometriosis Market Overview
23.2. North America Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Endometriosis Market

24.1. USA Endometriosis Market Overview
24.2. USA Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Endometriosis Market

25.1. Canada Endometriosis Market Overview
25.2. Canada Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Endometriosis Market

26.1. South America Endometriosis Market Overview
26.2. South America Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Endometriosis Market

27.1. Brazil Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Endometriosis Market

28.1. Middle East Endometriosis Market Overview
28.2. Middle East Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Endometriosis Market

29.1. Africa Endometriosis Market Overview
29.2. Africa Endometriosis Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Endometriosis Market, Segmentation By Treatment Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Endometriosis Market, Segmentation By End-User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Endometriosis Market Competitive Landscape And Company Profiles

30.1. Endometriosis Market Competitive Landscape
30.2. Endometriosis Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. F. Hoffmann-La Roche AG
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Merck And Co. Inc.
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Abbvie Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Bayer AG
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Endometriosis Market Other Major And Innovative Companies

31.1. Bristol-Myers Squibb Company
31.2. GlaxoSmithKline plc
31.3. AstraZeneca plc
31.4. Abbott Laboratories
31.5. Eli Lilly and Company
31.6. Mylan N.V.
31.7. Astellas Pharma Inc.
31.8. Sun Pharmaceutical Industries Ltd.
31.9. Teva Pharmaceutical Industries Limited
31.10. Ipsen Pharma Biotech S.A.S.
31.11. Cadila Pharmaceuticals Ltd.
31.12. Gedeon Richter plc
31.13. Torrent Pharmaceuticals Ltd.
31.14. Neurocrine Biosciences Inc.
31.15. Ferring Pharmaceuticals

32. Global Endometriosis Market Competitive Benchmarking

33. Global Endometriosis Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Endometriosis Market

35. Endometriosis Market Future Outlook and Potential Analysis

35.1 Endometriosis Market In 2028 - Countries Offering Most New Opportunities
35.2 Endometriosis Market In 2028 - Segments Offering Most New Opportunities
35.3 Endometriosis Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer